يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Bakhtiarvand, VK"', وقت الاستعلام: 0.76s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Myeloid-derived suppressor cells (MDSCs) depletion by cabozantinib improves the efficacy of anti-HER2 antibody-based immunotherapy in a 4T1-HER2 murine breast cancer model

    المؤلفون: Bakhtiarvand, VK, Akbari, KRA, Jalali, SA, Hojjat-Farsangi, M, Jeddi-Tehrani, M, Shokri, F, Shabani, M

    المصدر: International immunopharmacology. 113(Pt B):109470

    مصطلحات موضوعية: Medicin och hälsovetenskap

    URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:154541064

    View record from ScienceDirect Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Establishment of a murine model of breast cancer expressing human epidermal growth factor receptor 2 (4T1-HER2).

    المؤلفون: Bakhtiarvand VK; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Akbari KR; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Sadri F; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran., Haghighat FN; Monoclonal Antibody Research Centre, Avicenna Research Institute, ACECR, Tehran, Iran., Hojjat-Farsangi M; Department of Oncology-Pathology, BioClinicum Karolinska University Hospital Solna and Karolinska Institute, 17164 Stockholm, Sweden., Shokri F; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran., Jeddi-Tehrani M; Monoclonal Antibody Research Centre, Avicenna Research Institute, ACECR, Tehran, Iran., Shabani M; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

    المصدر: Journal of cancer research and therapeutics [J Cancer Res Ther] 2024 Apr 01; Vol. 20 (3), pp. 984-992. Date of Electronic Publication: 2023 Apr 04.

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Medknow Publications Country of Publication: India NLM ID: 101249598 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1998-4138 (Electronic) Linking ISSN: 19984138 NLM ISO Abbreviation: J Cancer Res Ther Subsets: MEDLINE

    مواضيع طبية MeSH: Breast Neoplasms*/pathology , Breast Neoplasms*/genetics , Breast Neoplasms*/metabolism , Breast Neoplasms*/therapy , Disease Models, Animal* , Receptor, ErbB-2*/metabolism , Receptor, ErbB-2*/genetics, Animals ; Female ; Humans ; Mice ; Antineoplastic Agents, Immunological/pharmacology ; Antineoplastic Agents, Immunological/therapeutic use ; Cell Line, Tumor ; Cell Proliferation ; Trastuzumab/pharmacology ; Trastuzumab/therapeutic use ; Xenograft Model Antitumor Assays

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء